Global CAR-T Cell Immunotherapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 80 pages | ID: G945644AEA13EN
LP Information

Abstracts

According to this study, the global CAR-T Cell Immunotherapy market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “CAR-T Cell Immunotherapy Industry Forecast” looks at past sales and reviews total world CAR-T Cell Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected CAR-T Cell Immunotherapy sales for 2025 through 2031. With CAR-T Cell Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Cell Immunotherapy industry.

This Insight Report provides a comprehensive analysis of the global CAR-T Cell Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-T Cell Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-T Cell Immunotherapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Cell Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Cell Immunotherapy.

This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Cell Immunotherapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• CD19
• CD22
• Other

Segmentation by Application:

• Relapsed or Refractory Mantle Cell Lymphoma (MCL)
• High Grade B Cell Lymphoma
• DLBCL
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis AG
• Kite Pharma
• JW Therapeutics
• Shanghai Fosun Pharmaceutical Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CAR-T Cell Immunotherapy Market Size (2020-2031)
  2.1.2 CAR-T Cell Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for CAR-T Cell Immunotherapy by Country/Region (2020, 2024 & 2031)
2.2 CAR-T Cell Immunotherapy Segment by Type
  2.2.1 CD19
  2.2.2 CD22
  2.2.3 Other
2.3 CAR-T Cell Immunotherapy Market Size by Type
  2.3.1 CAR-T Cell Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global CAR-T Cell Immunotherapy Market Size Market Share by Type (2020-2025)
2.4 CAR-T Cell Immunotherapy Segment by Application
  2.4.1 Relapsed or Refractory Mantle Cell Lymphoma (MCL)
  2.4.2 High Grade B Cell Lymphoma
  2.4.3 DLBCL
  2.4.4 Other
2.5 CAR-T Cell Immunotherapy Market Size by Application
  2.5.1 CAR-T Cell Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global CAR-T Cell Immunotherapy Market Size Market Share by Application (2020-2025)

3 CAR-T CELL IMMUNOTHERAPY MARKET SIZE BY PLAYER

3.1 CAR-T Cell Immunotherapy Market Size Market Share by Player
  3.1.1 Global CAR-T Cell Immunotherapy Revenue by Player (2020-2025)
  3.1.2 Global CAR-T Cell Immunotherapy Revenue Market Share by Player (2020-2025)
3.2 Global CAR-T Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CAR-T CELL IMMUNOTHERAPY BY REGION

4.1 CAR-T Cell Immunotherapy Market Size by Region (2020-2025)
4.2 Global CAR-T Cell Immunotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas CAR-T Cell Immunotherapy Market Size Growth (2020-2025)
4.4 APAC CAR-T Cell Immunotherapy Market Size Growth (2020-2025)
4.5 Europe CAR-T Cell Immunotherapy Market Size Growth (2020-2025)
4.6 Middle East & Africa CAR-T Cell Immunotherapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
5.2 Americas CAR-T Cell Immunotherapy Market Size by Type (2020-2025)
5.3 Americas CAR-T Cell Immunotherapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC CAR-T Cell Immunotherapy Market Size by Region (2020-2025)
6.2 APAC CAR-T Cell Immunotherapy Market Size by Type (2020-2025)
6.3 APAC CAR-T Cell Immunotherapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe CAR-T Cell Immunotherapy Market Size by Country (2020-2025)
7.2 Europe CAR-T Cell Immunotherapy Market Size by Type (2020-2025)
7.3 Europe CAR-T Cell Immunotherapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CAR-T Cell Immunotherapy by Region (2020-2025)
8.2 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Type (2020-2025)
8.3 Middle East & Africa CAR-T Cell Immunotherapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CAR-T CELL IMMUNOTHERAPY MARKET FORECAST

10.1 Global CAR-T Cell Immunotherapy Forecast by Region (2026-2031)
  10.1.1 Global CAR-T Cell Immunotherapy Forecast by Region (2026-2031)
  10.1.2 Americas CAR-T Cell Immunotherapy Forecast
  10.1.3 APAC CAR-T Cell Immunotherapy Forecast
  10.1.4 Europe CAR-T Cell Immunotherapy Forecast
  10.1.5 Middle East & Africa CAR-T Cell Immunotherapy Forecast
10.2 Americas CAR-T Cell Immunotherapy Forecast by Country (2026-2031)
  10.2.1 United States Market CAR-T Cell Immunotherapy Forecast
  10.2.2 Canada Market CAR-T Cell Immunotherapy Forecast
  10.2.3 Mexico Market CAR-T Cell Immunotherapy Forecast
  10.2.4 Brazil Market CAR-T Cell Immunotherapy Forecast
10.3 APAC CAR-T Cell Immunotherapy Forecast by Region (2026-2031)
  10.3.1 China CAR-T Cell Immunotherapy Market Forecast
  10.3.2 Japan Market CAR-T Cell Immunotherapy Forecast
  10.3.3 Korea Market CAR-T Cell Immunotherapy Forecast
  10.3.4 Southeast Asia Market CAR-T Cell Immunotherapy Forecast
  10.3.5 India Market CAR-T Cell Immunotherapy Forecast
  10.3.6 Australia Market CAR-T Cell Immunotherapy Forecast
10.4 Europe CAR-T Cell Immunotherapy Forecast by Country (2026-2031)
  10.4.1 Germany Market CAR-T Cell Immunotherapy Forecast
  10.4.2 France Market CAR-T Cell Immunotherapy Forecast
  10.4.3 UK Market CAR-T Cell Immunotherapy Forecast
  10.4.4 Italy Market CAR-T Cell Immunotherapy Forecast
  10.4.5 Russia Market CAR-T Cell Immunotherapy Forecast
10.5 Middle East & Africa CAR-T Cell Immunotherapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market CAR-T Cell Immunotherapy Forecast
  10.5.2 South Africa Market CAR-T Cell Immunotherapy Forecast
  10.5.3 Israel Market CAR-T Cell Immunotherapy Forecast
  10.5.4 Turkey Market CAR-T Cell Immunotherapy Forecast
10.6 Global CAR-T Cell Immunotherapy Forecast by Type (2026-2031)
10.7 Global CAR-T Cell Immunotherapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market CAR-T Cell Immunotherapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis AG
  11.1.1 Novartis AG Company Information
  11.1.2 Novartis AG CAR-T Cell Immunotherapy Product Offered
  11.1.3 Novartis AG CAR-T Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis AG Main Business Overview
  11.1.5 Novartis AG Latest Developments
11.2 Kite Pharma
  11.2.1 Kite Pharma Company Information
  11.2.2 Kite Pharma CAR-T Cell Immunotherapy Product Offered
  11.2.3 Kite Pharma CAR-T Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Kite Pharma Main Business Overview
  11.2.5 Kite Pharma Latest Developments
11.3 JW Therapeutics
  11.3.1 JW Therapeutics Company Information
  11.3.2 JW Therapeutics CAR-T Cell Immunotherapy Product Offered
  11.3.3 JW Therapeutics CAR-T Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 JW Therapeutics Main Business Overview
  11.3.5 JW Therapeutics Latest Developments
11.4 Shanghai Fosun Pharmaceutical Group
  11.4.1 Shanghai Fosun Pharmaceutical Group Company Information
  11.4.2 Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Product Offered
  11.4.3 Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Shanghai Fosun Pharmaceutical Group Main Business Overview
  11.4.5 Shanghai Fosun Pharmaceutical Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. CAR-T Cell Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CAR-T Cell Immunotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CD19
Table 4. Major Players of CD22
Table 5. Major Players of Other
Table 6. CAR-T Cell Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global CAR-T Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 8. Global CAR-T Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Table 9. CAR-T Cell Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global CAR-T Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 11. Global CAR-T Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Table 12. Global CAR-T Cell Immunotherapy Revenue by Player (2020-2025) & ($ millions)
Table 13. Global CAR-T Cell Immunotherapy Revenue Market Share by Player (2020-2025)
Table 14. CAR-T Cell Immunotherapy Key Players Head office and Products Offered
Table 15. CAR-T Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global CAR-T Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 19. Global CAR-T Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Table 20. Global CAR-T Cell Immunotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global CAR-T Cell Immunotherapy Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas CAR-T Cell Immunotherapy Market Size Market Share by Country (2020-2025)
Table 24. Americas CAR-T Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas CAR-T Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Table 26. Americas CAR-T Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas CAR-T Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Table 28. APAC CAR-T Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC CAR-T Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Table 30. APAC CAR-T Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC CAR-T Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe CAR-T Cell Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe CAR-T Cell Immunotherapy Market Size Market Share by Country (2020-2025)
Table 34. Europe CAR-T Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe CAR-T Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa CAR-T Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of CAR-T Cell Immunotherapy
Table 40. Key Market Challenges & Risks of CAR-T Cell Immunotherapy
Table 41. Key Industry Trends of CAR-T Cell Immunotherapy
Table 42. Global CAR-T Cell Immunotherapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global CAR-T Cell Immunotherapy Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global CAR-T Cell Immunotherapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global CAR-T Cell Immunotherapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Novartis AG Details, Company Type, CAR-T Cell Immunotherapy Area Served and Its Competitors
Table 47. Novartis AG CAR-T Cell Immunotherapy Product Offered
Table 48. Novartis AG CAR-T Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Novartis AG Main Business
Table 50. Novartis AG Latest Developments
Table 51. Kite Pharma Details, Company Type, CAR-T Cell Immunotherapy Area Served and Its Competitors
Table 52. Kite Pharma CAR-T Cell Immunotherapy Product Offered
Table 53. Kite Pharma CAR-T Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Kite Pharma Main Business
Table 55. Kite Pharma Latest Developments
Table 56. JW Therapeutics Details, Company Type, CAR-T Cell Immunotherapy Area Served and Its Competitors
Table 57. JW Therapeutics CAR-T Cell Immunotherapy Product Offered
Table 58. JW Therapeutics CAR-T Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. JW Therapeutics Main Business
Table 60. JW Therapeutics Latest Developments
Table 61. Shanghai Fosun Pharmaceutical Group Details, Company Type, CAR-T Cell Immunotherapy Area Served and Its Competitors
Table 62. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Product Offered
Table 63. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Shanghai Fosun Pharmaceutical Group Main Business
Table 65. Shanghai Fosun Pharmaceutical Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. CAR-T Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Cell Immunotherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CAR-T Cell Immunotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CAR-T Cell Immunotherapy Sales Market Share by Country/Region (2024)
Figure 8. CAR-T Cell Immunotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CAR-T Cell Immunotherapy Market Size Market Share by Type in 2024
Figure 10. CAR-T Cell Immunotherapy in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Figure 11. Global CAR-T Cell Immunotherapy Market: Relapsed or Refractory Mantle Cell Lymphoma (MCL) (2020-2025) & ($ millions)
Figure 12. CAR-T Cell Immunotherapy in High Grade B Cell Lymphoma
Figure 13. Global CAR-T Cell Immunotherapy Market: High Grade B Cell Lymphoma (2020-2025) & ($ millions)
Figure 14. CAR-T Cell Immunotherapy in DLBCL
Figure 15. Global CAR-T Cell Immunotherapy Market: DLBCL (2020-2025) & ($ millions)
Figure 16. CAR-T Cell Immunotherapy in Other
Figure 17. Global CAR-T Cell Immunotherapy Market: Other (2020-2025) & ($ millions)
Figure 18. Global CAR-T Cell Immunotherapy Market Size Market Share by Application in 2024
Figure 19. Global CAR-T Cell Immunotherapy Revenue Market Share by Player in 2024
Figure 20. Global CAR-T Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 21. Americas CAR-T Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 22. APAC CAR-T Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 23. Europe CAR-T Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa CAR-T Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 25. Americas CAR-T Cell Immunotherapy Value Market Share by Country in 2024
Figure 26. United States CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC CAR-T Cell Immunotherapy Market Size Market Share by Region in 2024
Figure 31. APAC CAR-T Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 32. APAC CAR-T Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 33. China CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 37. India CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe CAR-T Cell Immunotherapy Market Size Market Share by Country in 2024
Figure 40. Europe CAR-T Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 41. Europe CAR-T Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 42. Germany CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. France CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 44. UK CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa CAR-T Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 50. Egypt CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries CAR-T Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 56. APAC CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 57. Europe CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 59. United States CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 60. Canada CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 61. Mexico CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 62. Brazil CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 63. China CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 64. Japan CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 65. Korea CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 67. India CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 68. Australia CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 69. Germany CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 70. France CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 71. UK CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 72. Italy CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 73. Russia CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 74. Egypt CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 75. South Africa CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 76. Israel CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 77. Turkey CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 78. Global CAR-T Cell Immunotherapy Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global CAR-T Cell Immunotherapy Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries CAR-T Cell Immunotherapy Market Size 2026-2031 ($ millions)